183 related articles for article (PubMed ID: 10738089)
1. Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control.
Kwissa M; von Kampen vK; Zurbriggen R; Glück R; Reimann J; Schirmbeck R
Vaccine; 2000 May; 18(22):2337-44. PubMed ID: 10738089
[TBL] [Abstract][Full Text] [Related]
2. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
Schirmbeck R; Reimann J
Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
[TBL] [Abstract][Full Text] [Related]
3. Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide.
Schirmbeck R; König-Merediz SA; Riedl P; Kwissa M; Sack F; Schroff M; Junghans C; Reimann J; Wittig B
J Mol Med (Berl); 2001 Jun; 79(5-6):343-50. PubMed ID: 11485031
[TBL] [Abstract][Full Text] [Related]
4. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses.
Böhm W; Mertens T; Schirmbeck R; Reimann J
Vaccine; 1998; 16(9-10):949-54. PubMed ID: 9682342
[TBL] [Abstract][Full Text] [Related]
5. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection.
Böhm W; Kuhröber A; Paier T; Mertens T; Reimann J; Schirmbeck R
J Immunol Methods; 1996 Jun; 193(1):29-40. PubMed ID: 8690928
[TBL] [Abstract][Full Text] [Related]
6. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
7. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.
McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL
Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545
[TBL] [Abstract][Full Text] [Related]
8. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
[TBL] [Abstract][Full Text] [Related]
9. Polyvalent DNA vaccines with bidirectional promoters.
Kwissa M; Unsinger J; Schirmbeck R; Hauser H; Reimann J
J Mol Med (Berl); 2000; 78(9):495-506. PubMed ID: 11140375
[TBL] [Abstract][Full Text] [Related]
10. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
11. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen.
Schirmbeck R; Zheng X; Roggendorf M; Geissler M; Chisari FV; Reimann J; Lu M
J Immunol; 2001 Jan; 166(2):1405-13. PubMed ID: 11145726
[TBL] [Abstract][Full Text] [Related]
12. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
Schirmbeck R; Böhm W; Ando K; Chisari FV; Reimann J
J Virol; 1995 Oct; 69(10):5929-34. PubMed ID: 7666497
[TBL] [Abstract][Full Text] [Related]
14. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
[TBL] [Abstract][Full Text] [Related]
15. A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model.
Zheng B; Woo PC; Ng M; Tsoi H; Wong L; Yuen K
Vaccine; 2001 Oct; 20(1-2):140-7. PubMed ID: 11567758
[TBL] [Abstract][Full Text] [Related]
16. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
Schirmbeck R; Reimann J
Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
[TBL] [Abstract][Full Text] [Related]
17. [Construction of eukaryotic expression plasmids inserting HBsAg gene and DNA immunization responses to HBsAg in mice].
Liang Z; Lan Y; Li Y; Cai D; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):106-8. PubMed ID: 11983125
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter.
Cazeaux N; Bennasser Y; Vidal PL; Li Z; Paulin D; Bahraoui E
Vaccine; 2002 Sep; 20(27-28):3322-31. PubMed ID: 12213402
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus.
Fomsgaard A; Nielsen HV; Nielsen C; Johansson K; Machuca R; Bruun L; Hansen J; Buus S
APMIS; 1998 Jun; 106(6):636-46. PubMed ID: 9725796
[TBL] [Abstract][Full Text] [Related]
20. Modulating specific priming of immune effector functions by DNA-based vaccination strategies.
Reimann J; Schirmbeck R
Dev Biol (Basel); 2000; 104():15-24. PubMed ID: 11713813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
